SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-021295
Filing Date
2017-11-02
Accepted
2017-11-02 17:16:51
Documents
2
Period of Report
2017-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20171031.htm 8-K 30732
2 EX-10.1 AMENDED LOAN AGREEMENT SVB MIDCAP clsd-ex101_6.htm EX-10.1 85262
  Complete submission text file 0001564590-17-021295.txt   117141
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 171173514
SIC: 2834 Pharmaceutical Preparations